Clara Schott

Clara Schott

Auto-generated profile, based on publicly available information

Clara Schott

Department of Biochemistry, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2026 in Kidney International
Verified
Journal Article
Open access
CSClara Schott
Clara Schott
SRSydney Relouw
Sydney Relouw
MAMonica Arnaldi
Monica Arnaldi
CBCadence Baker
Cadence Baker
GOGabriela Offerni-Almada
Gabriela Offerni-Almada
DCDervla M Connaughton
Dervla M Connaughton
The cause of kidney failure in kidney transplant recipients remains unknown in 20-45% of cases. Outcomes for living kidney donors (LKDs) are generally excellent, with only 8% experiencing complications post-donation. Here, we hypothesize that genetic testing could identify a genetic etiology in at least 20% of recipients and inform risk stratification in LKDs. Genetic testing was performed in 231 transplant recipients and 46 prospective LKDs by means of exome sequencing of 409 chronic kidney disease (CKD)-associated genes. We also assessed 122 retrospective LKDs who developed adverse kidney outcomes post-donation which were defined by at least two of the three criteria: hypertension, a glomerular filtration rate under 60 mL/min/1.73m2, or a urine albumin to creatinine ratio of 3 mg/mmol or more. Pathogenic or likely pathogenic (P/LP) variants were identified in 23% of recipients, most commonly involving genes associated with cystic kidney disease and glomerulopathies. Among the recipients with a genetic diagnosis, there was a 37% rate of reclassification to a different phenotype post genetic testing. Among prospective LKDs, 4% had P/LP variants. In the retrospective cohort of LKDs with adverse kidney outcomes post donation, 19% carried P/LP variants. Genetic testing yielded a high diagnostic rate and frequently reclassified CKD etiology in transplant recipients, underscoring its diagnostic utility. Universal genetic testing of asymptomatic LKDs had a yield of 4%, although our prospective LKD cohort had limited sample size. In contrast, high proportion of LKDs with adverse kidney outcome post-donation were found to carry P/LP variants in CKD-associated genes. Our findings suggest that targeted genetic testing of high-risk donors may be a preferred over universal testing strategy to optimize donor selection in LKDs. However, further evaluation is warranted to ensure this approach appropriately balances donor safety with equitable access.

31 March 2025 in Genes
Verified
Journal Article
Open access
CSClara Schott
Clara Schott
MAMohammad Alajmi
Mohammad Alajmi
MBMohammad Bukhari
Mohammad Bukhari
SRSydney Relouw
Sydney Relouw
JWJian Wang
Jian Wang
DCDervla M Connaughton
Dervla M Connaughton
Background: Genetic causes of chronic diseases, once considered rare in adult-onset disease, now account for between 10 and 20% of cases of chronic kidney disease (CKD). Confirming a genetic diagnosis can influence disease management; however, the utility of genetic testing in older adults remains poorly understood, partly due to age-based restrictions on testing access. To better evaluate the diagnostic yield and clinical utility of genetic testing in this population, we analyzed data from adults aged ≥50 years with CKD who were assessed in a specialized kidney genetics clinic. Methods: We studied a cohort of 125 adults with CKD aged ≥50 years at the time of genetic testing. Genetic testing included gene panels targeting disease-related genes based on clinical phenotype, and/or exome sequencing for additional monogenic causes if the initial panel testing was inconclusive. Results: Pathogenic variants in disease-related genes were identified in 38% of patients. The highest diagnostic yield (48%) was in patients aged 50–54 years. The most common diagnosis post-testing was glomerulopathies (32%). Clinical utility, shown through the case series, included modifications to treatment and clinical management, as well as a reduction in the diagnostic odyssey. Conclusions: Our findings from a dedicated Kidney Genetics Clinic show that genetic testing in adults ≥50 years with CKD has significant diagnostic and clinical utility. These results support guideline recommendations that there should be no upper age limit for genetic testing. Future research in unselected CKD populations is needed to establish the broader applicability and feasibility of genetic testing in older adults.

18 September 2026 in Kidney International
Verified
Journal Article
Closed access
CSClara Schott
Clara Schott
MAMonica Arnaldi
Monica Arnaldi
DCDervla M. Connaughton
Dervla M. Connaughton

1 March 2026 in Advances in Physiology Education
Verified
Journal Article
Closed access
FHFaraj L. Haddad
Faraj L. Haddad
CSClara Schott
Clara Schott
JKJina J. Y. Kum
Jina J. Y. Kum
Teaching assistants (TAs) are often the main source of feedback on scientific writing in undergraduate physiology and biomedical science courses, but most have not been trained to do it well. We created a course-level intervention to help graduate TAs give more useful feedback. Our practical approach, which involved a 1-day workshop and the development of course-specific feedback guidelines, can be scaled and adapted to improve the teaching and learning of scientific communication skills.

18 September 2026 in Kidney International
Verified
Journal Article
Closed access
CSClara Schott
Clara Schott
MAMonica Arnaldi
Monica Arnaldi
KSKarla Solo
Karla Solo
DCDervla M. Connaughton
Dervla M. Connaughton